sulfamethoxazole has been researched along with Carcinoma, Transitional Cell in 1 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ikeuchi, H | 1 |
Ozasa, Y | 1 |
Sasaki, S | 1 |
Oshima, M | 1 |
1 other study available for sulfamethoxazole and Carcinoma, Transitional Cell
Article | Year |
---|---|
[A case of pneumocystis carinii pneumonia after chemotherapy of bladder tumor].
Topics: Aged; Carcinoma, Transitional Cell; Doxorubicin; Drug Combinations; Humans; Male; Pneumonia, Pneumoc | 1985 |